Votre sélection est vide.
Sélectionnez des ETF pour les comparer les uns aux autres.
Ajoutez un ETF à la sélection en le sélectionnant dans le sélecteur d’ETF ou sous « Comparer » sous le profil de l’ETF.
BridgeBio Pharma, Inc.
ISIN US10806X1028
|Code du titre A2PLX7
Cap. boursière (en EUR)
10,415 m
Country
United States
Secteur
Healthcare
Rendement en dividendes
0.00%
Aperçu
Description
BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Francis Patrick McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States
Financials
Key metrics
| Market capitalisation, EUR | 10,415 m |
| EPS, EUR | -3.79 |
| P/B ratio | - |
| P/E ratio | - |
| Dividend yield | 0.00% |
Income statement (2024)
| Revenue, EUR | 205 m |
| Net income, EUR | -495 m |
| Profit margin | -241.44% |
What ETF is BridgeBio Pharma, Inc. in?
There are 4 ETFs which contain BridgeBio Pharma, Inc.. All of these ETFs are listed in the table below. The ETF with the largest weighting of BridgeBio Pharma, Inc. is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 1.08% | Equity United States Health Care Biotech | 47 |
| Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.01% | Equity World Social/Environmental | 489 |
| Vanguard ESG North America All Cap UCITS ETF (USD) Distributing | 0.02% | Equity North America Social/Environmental | 25 |
| JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) | 0.17% | Equity United States Small Cap | 192 |
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.